Clinical Trial Update: DISCOVERY Asia - Crestor in Type IIa and IIb Hypercholesteremia [Phase 3]

View source ↗

Summary

DISCOVERY Asia Phase 3 trial of Crestor (rosuvastatin) for type IIa and IIb hypercholesterolemia has completed.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Hypercholesterolemia

Drugs mentioned

• CRESTOR (Rosuvastatin)

Snippet

Sponsor: AstraZeneca | Conditions: Hypercholesterolemia | Phase 3 | Status: COMPLETED